158 related articles for article (PubMed ID: 19772811)
1. Successful treatment of ankylosing spondylitis coexisting with pulmonary sarcoidosis by infliximab.
Ochi S; Nanki T; Kaneko H; Honne K; Miyazaki Y; Komano Y; Miyasaka N
Clin Exp Rheumatol; 2009; 27(4):698-9. PubMed ID: 19772811
[No Abstract] [Full Text] [Related]
2. Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab.
Almodóvar R; Izquierdo M; Zarco P; Javier Quirós F; Mazzucchelli R; Steen B
Clin Exp Rheumatol; 2007; 25(1):99-101. PubMed ID: 17417999
[TBL] [Abstract][Full Text] [Related]
3. [Sarcoidosis and ankylosing spondylitis. A case report and review of the literature].
Abouzahir A; El Maghraoui A; Tabache F; Bezza A; Chaari J; Ghafir D; Ohayon V; Archane MI
Ann Med Interne (Paris); 2002 Oct; 153(6):407-10. PubMed ID: 12486391
[TBL] [Abstract][Full Text] [Related]
4. Infliximab therapy for inflammatory discitis in ankylosing spondylitis.
Joshi N; Nautiyal A; Walton T
J Clin Rheumatol; 2012 Mar; 18(2):109-10. PubMed ID: 22367694
[No Abstract] [Full Text] [Related]
5. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
Rebelo A; Leite S; Cotter J
BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
[TBL] [Abstract][Full Text] [Related]
6. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study].
Bunchuk NV; Rumiantseva OA; Loginova EIu; Bochkova AG; Storozhakov GI; Ettinger OA; Kosiura SD; Kamalova RG; Valishina LM
Ter Arkh; 2010; 82(10):41-6. PubMed ID: 21341463
[TBL] [Abstract][Full Text] [Related]
8. Infliximab therapy in pulmonary sarcoidosis.
Kähler CM; Heininger P; Loeffler-Ragg J; Vogelsinger H
Am J Respir Crit Care Med; 2007 Aug; 176(4):417; author reply 417-8. PubMed ID: 17675452
[No Abstract] [Full Text] [Related]
9. Infliximab reduces oxidative stress in ankylosing spondylitis.
Feijóo M; Túnez I; Tasset I; Montilla P; Ruiz A; Collantes E
Clin Exp Rheumatol; 2009; 27(1):167-8; author reply 168. PubMed ID: 19327250
[No Abstract] [Full Text] [Related]
10. Vertebral sarcoid mimicking ankylosing spondylitis or just a co-incidence?
Malaviya AN; Sawhney S; Kapoor S; Garg S
J Assoc Physicians India; 2010 Nov; 58():709-11. PubMed ID: 21510471
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis.
Alabed IB; Qushmaq KA; Khan MA
Saudi Med J; 2010 Sep; 31(9):1054-6. PubMed ID: 20844821
[TBL] [Abstract][Full Text] [Related]
12. [Sarcoidosis (Boeck's disease). Inflammatory granulomatous systemic disease which involves especially the lung and lymph nodes].
Pabst S; Vetter H; Grohé Ch
Praxis (Bern 1994); 2004 Oct; 93(42):1717-22; quiz 1723-4. PubMed ID: 15529958
[No Abstract] [Full Text] [Related]
13. Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis.
Ngai JC; Lam R; Ko FW; To KW; Hui DS
Thorax; 2009 Feb; 64(2):184. PubMed ID: 19176849
[No Abstract] [Full Text] [Related]
14. Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?
Vilela Lopes R; Barros Ohashi C; Helena Cavaleiro L; de Britto Pereira Cruz R; da Veiga RR; Fernando Ribeiro Miranda M; Toshimitsu Yoshikawa G
Clin Rheumatol; 2009 May; 28(5):615-7. PubMed ID: 19259757
[TBL] [Abstract][Full Text] [Related]
15. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
[TBL] [Abstract][Full Text] [Related]
16. [Lung caverns in sarcoidosis with nodular liver and spleen involvement].
Brader P; Scheidl S; Reittner P
Rofo; 2004 Oct; 176(10):1515-7. PubMed ID: 15383990
[No Abstract] [Full Text] [Related]
17. Pulmonary Sarcoidosis Induced by Anti-Tumor Necrosis Factor Therapy: A Paradoxical Effect.
Aliel Vigano Pugliesi A; Zerbini Mariano R; Matsunaga De Angelis C; Barros Bertolo M; Alexandre Yazbek M
J Clin Rheumatol; 2020 Jan; 26(1):23-24. PubMed ID: 29667945
[No Abstract] [Full Text] [Related]
18. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda J; González-Juanatey C; Llorca J; González-Gay MA
Clin Exp Rheumatol; 2013; 31(5):749-55. PubMed ID: 23806325
[TBL] [Abstract][Full Text] [Related]
19. Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy.
Genre F; López-Mejías R; Miranda-Filloy JA; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda J; González-Juanatey C; Llorca J; González-Gay MÁ
Clin Exp Rheumatol; 2013; 31(6):913-8. PubMed ID: 23981480
[TBL] [Abstract][Full Text] [Related]
20. Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis.
Marocchi E; Spadaro A; Giannakakis K; Priori R; Valesini G
Clin Exp Rheumatol; 2010; 28(3):440. PubMed ID: 20576230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
